Skip to main content
Fig. 2 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 2

From: Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT

Fig. 2

The [68Ga]Ga-PSMA-11 PET/CT images of a 63 years old patient who received cabazitaxel following goserelin and docetaxel before (a) and after (b) therapy. Despite decreasing of serum PSA from 382 ng/ml to 236 ng/dl and considering the patient in biochemically stable group, new metastatic abdominal paraaortic lymph nodes and bone lesions were detected and [68 Ga]Ga-PSMA-11 uptakes of those were increased significantly (arrows)

Back to article page